Eric Friedman Buys 50,000 Shares of INBP
Eric Friedman made a significant purchase of 50,000 shares in INBP on June 24, 2026.
Key Points
- Eric Friedman bought 50,000 shares of INBP on June 24, 2026, with each share trading at $0.18.
- INBP shares were trading near $0.18 on Thursday, but specific financial metrics were not disclosed.
- Alongside Friedman, insiders Damon DeSantis, Robert Canarick, and William Milmoe also bought 50,000 shares each.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 24, 2026, Eric Friedman purchased 50,000 shares of INBP. The transaction did not disclose a specific price, but shares traded at approximately $0.18 on Thursday.
Insider Buying and Selling at Integrated BioPharma, Inc.
Several insiders were active in INBP on June 24, 2026. Along with Eric Friedman, Damon DeSantis, Robert Canarick, and William Milmoe each bought 50,000 shares. These transactions were not part of any pre-planned trading program. Earlier, on April 15, 2026, William Milmoe also sold 11,201,964 shares, marking a significant change in his holdings.
Bottom Line
Eric Friedman's recent purchase of INBP shares highlights continued insider interest in the company. Insider transactions can offer clues about how those closest to the company view its prospects. However, these filings are historical and may not reflect current positions.
Get Integrated BioPharma, Inc. alerts
New 13F filings, insider trades, and analyst moves on $INBP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.